XM levert geen diensten aan inwoners van de Verenigde Staten.
D
D

DardenRestaurants


Nieuws

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Attica Bank, Kuvimba Mining House, Leonardo, Asterion; updates Meta Platforms July 18 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1 930 GMT on Thursday: * * Attica Bank BOAr.AT , Greece's fifth largest lender, announced that it had finalised a deal to merge with the smaller Pancretan Bank in an effort to clean up its balance sheet and create a new banking organisation.
F
R
A
D

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Meta, CommScope, Clayton, Dubilier & Rice, Schenker July 18 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: ** Meta Platforms META.O has explored a multibillion-euro investment in eyewear group EssilorLuxottica ESLX.PA , the Financial Times reported.
F
A
D

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions July 18 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Thursday: ** Apax Partners, Bain Capital and CVC CVC.AS are each exploring potential bids for SoftwareOne SWON.S , two people with knowledge of the situation said, three months after the ouster of the Swiss software company's board.
F
D

Wall Street Journal - July 18

PRESS DIGEST -Wall Street Journal - July 18 July 18 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Darden Restaurants DRI.N agreed to buy Chuy's Holdings CHUY.O for about $605 million, adding a Tex-Mex restaurant chain to a portfolio that includes Olive Garden, LongHorn Steakhouse and more.
D

Olive Garden parent Darden to buy Chuy's in $605 mln deal

Olive Garden parent Darden to buy Chuy's in $605 mln deal July 17 (Reuters) - Darden Restaurants DRI.N , owner of the Olive Garden chain, has agreed to buy full-service restaurant operator Chuy's Holdings CHUY.O in an all-cash deal which has an enterprise value of $605 million, the companies said on Wednesday. The move would add 101 restaurants operated by Chuy's across 15 states in the U.S.
D

U.S. CoreCivic, Eli Lilly, 40

U.S. RESEARCH ROUNDUP-CoreCivic, Eli Lilly, WD-40 July 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CoreCivic , Eli Lilly and WD -40, on Thursday. HIGHLIGHTS * Antero Resources Corp AR.N : Gerdes Energy Research raises to buy from neutral * CoreCivic Inc CXW.N : Jonestrading initiates coverage with hold rating * Costco Wholesale Corp COST.O : Jefferies raises target price to $1050 from $860 * Eli Lilly LLY.N :
C
F
E
E
E
I
D

Street View: Darden 'stays the course' in challenging backdrop with Q4 profit beat

BUZZ-Street View: Darden 'stays the course' in challenging backdrop with Q4 profit beat ** Olive Garden owner Darden Restaurants DRI.N reported upbeat fourth-quarter profit, helped by lower input costs, including labor ** At least three brokerages raised PT on the stock; their median PT is $175 - LSEG DARDEN BENEFITS FROM MODERATE PRICING, HIGH SER
D

U.S. CME Group, Ingersoll Rand, Winnebago Industries

U.S. RESEARCH ROUNDUP-CME Group, Ingersoll Rand, Winnebago Industries June 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CME Group, Ingersoll Rand and Winnebago Industries, on Friday. HIGHLIGHTS * CME Group Inc CME.O : JP Morgan cuts to underweight from neutral * Ingersoll Rand Inc IR.N : Jefferies resumes coverage with buy rating; PT $110 * Nike Inc NKE.N : Oppenheimer raises to outperform from perform * Sarept
A
A
C
K
M
M
N
N
G
I
A
D

U.S. STOCKS Allstate, MicroStrategy, AutoZone

BUZZ-U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq hit record highs on Thursday, boosted by strong gains in Nvidia, while investors assessed recent economic data and commentary from Federal Reserve officials to gauge the timing of interest-rate cuts this year.
G
K
M
N
U
U
D
A
D

U.S. STOCKS Allstate, MicroStrategy, AutoZone

BUZZ-U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The benchmark S&P 500 touched a record high on Thursday, boosted by strong gains in Nvidia, while investors assessed the recent economic data and commentary from Federal Reserve officials to gauge the timing for interest rate cuts this year.
G
K
N
A
U
U
D
D

Darden Restaurants up after upbeat Q4 profit

BUZZ-Darden Restaurants up after upbeat Q4 profit ** Shares of Olive Garden parent Darden Restaurants DRI.N up ~1% at $153.90 premarket ** Co logs quarterly adj. profit of $2.65 per share vs analysts' estimates of $2.61 per share owing to lower labor costs and marketing expenses ** Same-store sales at LongHorn Steakhouse business rose 4% vs 2.3% ri
D

Olive Garden-owner Darden beats estimates for quarterly profit

Olive Garden-owner Darden beats estimates for quarterly profit June 20 - Darden Restaurants DRI.N beat market expectations for fourth-quarter profit on Thursday, as higher menu prices and lower wages more than offset rising costs of meat and cooking ingredients, sending its shares up 3% in premarket trading. The Orlando, Florida-based company said menu prices were steadily pushed up to soften the blow of sticky inflation, while its high-end chains, Olive Garden and LongHorn Steakhouse, continued
S
D

Darden Q4 Adjusted EPS Continuing Operations USD 2.65 Vs. IBES Estimate USD 2.61

BRIEF-Darden Q4 Adjusted EPS Continuing Operations USD 2.65 Vs. IBES Estimate USD 2.61 Jun 20 (Reuters) - Darden Q4 sales USD 3,000 million vs. IBES estimate USD 2,972 million. Q4 EPS continuing operations USD 2.58
D

Stocks up as Swiss cut again, BoE eyed; yuan slides

MORNING BID AMERICAS-Stocks up as Swiss cut again, BoE eyed; yuan slides A look at the day ahead in U.S. and global markets from Mike Dolan Wall Street returns from its midweek break to find record high stocks still chomping at the bit, with overseas monetary easing in focus as the Swiss cut interest rates for the second time this year and the Bank of England decision now awaited.
C
G
K
M
N
T
U
U
J
U
U
F
A
D

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
C
C
D
M

Darden Restaurants Inc <DRI.N> expected to post earnings of $2.61 a share - Earnings Preview

Darden Restaurants Inc expected to post earnings of $2.61 a share - Earnings Preview Darden Restaurants Inc DRI.N , DRI is expected to show a rise in quarterly revenue when it reports results on June 20 for the period ending May 31 2024 The Orlando Florida-based company is expected to report a 7.4% increase in revenue to $2.973 billion from $2.77 billion a year ago, according to the mean estimate from 22 analysts, based on LSEG data.The company's guidance on March 21 2024, for the period ended M
D

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
U
T
C
C
D
M

U.S. earnings week ahead

DIARY-U.S. earnings week ahead June 14 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 17-Jun-2024 AMC LEN Lennar Corp Q2 2024 Lennar Corp Earnings Release 20-Jun-2024 BMO KR Kroger Co Q1 2024 Kroger Co Earnings Release 20-Jun-2024 BMO JBL Jabil Inc Q3 2024 Jabil Inc Earnings Release 20-Jun-2024 BMO DRI Darden Restaurants Inc Q4 2024
K
U
C
D

U.S. Adobe, Oracle, Zscaler

U.S. RESEARCH ROUNDUP-Adobe, Oracle, Zscaler June 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Oracle Corp and Zscaler, on Friday. HIGHLIGHTS * Adobe Inc ADBE.O : Baird raises target price to $545 from $525 * Bandwidth Inc BAND.O : Morgan Stanley cuts to underweight from equal-weight * Corpay Inc CPAY.N : Jefferies cuts target price to $295 from $330 * Oracle Corp ORCL.N : Berenberg raises target price t
A
A
A
B
H
H
M
B
C
D

U.S. Avidity Biosciences, Broadcom, Cara Therapeutics

U.S. RESEARCH ROUNDUP-Avidity Biosciences, Broadcom, Cara Therapeutics June 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avidity Biosciences, Broadcom and Cara Therapeutics, on Thursday. HIGHLIGHTS * Avidity Biosciences Inc RNA.O : Leerink Partners raises target price to $56 from $38 * Broadcom Inc AVGO.O : TD Cowen raises target price to $1,750 from $1,500 * Cara Therapeutics Inc CARA.O : Canaccord Genuity cut
B
B
C
C
G
M
C
A
D
I
L



Voorwaarden

Populaire activa

Disclaimer: De entiteiten van de XM Group bieden diensten en toegang tot ons online handelsplatform op basis van uitsluitend-uitvoering, waardoor een persoon de beschikbare content op of via de website kan bekijken en/of gebruiken, zonder dat dit is bedoeld voor wijziging of uitbreiding. Dergelijk(e) toegang en gebruik vallen onder: (i) de algemene voorwaarden; (ii) risicowaarschuwingen; en de (iii) volledige disclaimer. Dergelijke content wordt daarom alleen aangeboden als algemene informatie. Wees u er daarnaast vooral van bewust dat de inhoud op ons online handelsplatform geen verzoek of aanbieding omvat om transacties op de financiële markten uit te voeren. Het beleggen op welke financiële markt dan ook vormt een aanzienlijk risico voor uw vermogen.

Alle materialen die op ons online handelsplatform worden gepubliceerd zijn bedoeld voor educatieve/informatieve doeleinden en omvatten geen – en moeten niet worden beschouwd als het bevatten van – financieel, vermogensbelastings- of handelsadvies en aanbevelingen, of een overzicht van onze handelsprijzen, of een aanbod of aanvraag van een transactie in financiële instrumenten of ongevraagde financiële promoties voor u.

Alle content van derden, alsmede content die is voorbereid door XM, zoals opinies, nieuws, onderzoeken, analyses, prijzen en andere informatie of koppelingen naar externe websites op deze website worden aangeboden op een 'zoals-ze-zijn'-basis, als algemene marktcommentaren, en vormen geen beleggingsadvies. Voor zover dat content wordt beschouwd als beleggingsonderzoek, moet u zich ervan bewust zijn en accepteren dat de content niet bedoeld was en niet is voorbereid in overeenstemming met de wettelijke vereisten die zijn opgesteld om de onafhankelijkheid van beleggingsonderzoek te bevorderen en als zodanig onder de geldende wetgeving en richtlijnen moet worden beschouwd als marketingcommunicatie. Zorg ervoor dat u onze Mededeling over niet-onafhankelijk beleggingsonderzoek en risicowaarschuwing in verband met de voorgaande informatie doorneemt en begrijpt; die kunt u hier lezen.

Risicowaarschuwing: Uw vermogen loopt risico. Hefboomproducten zijn mogelijk niet voor iedereen geschikt. Lees onze informatie over risico's.